The original success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies strongly reliant on unbranded versions presents a complex picture. While early profits were impressive, the expiration of patents and the rise of discounted alternatives have weakened the customer base. Therefore, a thorough analysis of present